2016


To access this material please log in or register

Register Authorize
2016/№2

Effects of depression and anxiety on clinical outcomes in patients with CHF

Drobizhev M. Yu.1, Begrambekova Yu. L.2, Mareev V. Yu.2, Kikta S. V.3
1 – State Budgetary Educational Institution of Higher Professional Education “I. M. Sechenov First Moscow State Medical University” of the RF Ministry of Health Care, Trubetskaya 8, Bldg. 2, Moscow 119991
2 – Federal State Budgetary Educational Institution of Higher Professional Education “M. V. Lomonosov Moscow State University”, Leninskie Gory 1, GSP-1, Moscow 119991
3 – Federal State Budgetary Institution, “Polyclinic #3” of the Department for Presidential Affairs of the Russian Federation, Grokholsky Pereulok., 31, Moscow 129090

Keywords: CHF, depression, anxiety, prognosis, mortality, hospitalisation

DOI: 10.18087/rhfj.2016.2.2206

Background. Many studies have demonstrated an independent effect of depression on HF prognosis. Most Western expert societies recommend to routinely screen for depression patients with cardiovascular diseases to refer them subsequently to a psychiatrist for treatment. However, convincing evidence for an effect of these interventions on the HF course are still not available. Aim. To study effects of depression and anxiety on mortality and hospitalization rate of CHF patients using a complex monofactorial and multifactorial analysis. Materials and methods. Using a mono- and then multifactorial statistical analyses we determined independent effects of depression and anxiety on prognosis for HF patients with NYHA Class III-IV included in the CHANCE study. The included patients were tested using a Hospital Anxiety and Depression Scale (HADS) at study week 0, and their demographic and clinical characteristics were recorded at the same time. Results. Using methods of the monofactorial analysis we studied the relationship between the following independent, mental status variables with mortality and hospitalizations: mean score of the HADS anxiety subscale; mean score of the HADS depression subscale; proportion of patients with anxiety; proportion of patients with moderate and severe depression; and proportion of patients with moderate and severe anxiety and depression. A significant relationship with mortality was found for the mean score of the HADS depression subscale with OR 1.09 [95 % CI 1.02–1.16] and proportion of patients with anxiety and depression with OR 1.24 [95 % CI 1.04–1.48]. None of the studied mental parameters showed a statistically significant relationship with hospitalization. The multiple logistic regression, in addition to mental factors, included clinical and demographic parameters that had shown the greatest impact on mortality in the monofactorial analysis: presence of a patient in the active group (OR 0.61 [95 % CI 0.37–0.99]); postinfarction cardiosclerosis (OR 2.54 [95 % CI 1.50–4.28]); CHF stage (OR 2.88 [95 % CI 1.86–4.46]); NYHA FC (OR 4.13 [95 % CI 2.54–6.72]); depression and a combination of depression and anxiety. When included into the multiple logistic regression, the parameters of mental status lost their relationship with mortality. Conclusion. This study did not demonstrate an independent effect of depressive and anxiety disorders on hospitalization and mortality of HF patients with NYHA FC III-IV.
  1. Vaccarino V, Kasl SV, Abramson J, Krumholz HM. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001 Jul;38 (1):199–205.
  2. Guck TP, Elsasser GN, Kavan MG, Barone EJ. Depression and congestive heart failure. Congest Heart Fail. 2003 May-Jun;9 (3):163–9.
  3. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med. 2007 Feb 26;167 (4):367–73.
  4. Jiang W, Kuchibhatla M, Clary GL, Cuffe MS, Christopher EJ, Alexander JD et al. Relationship between depressive symptoms and long-term mortality in patients with heart failure. Am Heart J. 2007 Jul;154 (1):102–8.
  5. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001 Aug 13–27;161 (15):1849–56.
  6. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006 Oct 17;48 (8):1527–37.
  7. Sherwood A, Blumenthal JA, Hinderliter AL, Koch GG, Adams KF Jr, Dupree CS et al. Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol. 2011 Jan 25;57 (4):418–23.
  8. Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E et al. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009 Apr;122 (4):366–73.
  9. Freedland KE, Carney RM, Rich MW. Effect of depression on prognosis in heart failure. Heart Fail Clin. 2011 Jan;7 (1):11–21.
  10. Fan H, Yu W, Zhang Q, Cao H, Li J, Wang J et al. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med. 2014 Jun;63:36–42.
  11. Xiong GL, Fiuzat M, Kuchibhatla M, Krishnan R, O’Connor CM, Jiang W. Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. Circ Heart Fail. 2012 Nov;5 (6):688–92.
  12. Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. Contemp Clin Trials. 2009 May;30 (3):205–11.
  13. Depression in adults with a chronic physical health problem: recognition and management. NICE clinical guideline 91. National Collaborating Centre for Mental Health (UK). – Leicester (UK): British Psychological Society, – 2010.
  14. Lichtman JH, Bigger JT Jr, Blumenthal JA, Frasure-Smith N, Kaufmann PG, Lesperance F et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research; endorsed by the American Psychiatric Association. Circulation. 2008 Oct 21;118 (17):1768–75.
  15. Woltz PC, Chapa DW, Friedmann E, Son H, Akintade B, Thomas SA. Effects of interventions on depression in heart failure: a systematic review. Heart Lung. 2012 Sep-Oct;41 (5):469–83.
  16. Мареев В. Ю., Беграмбекова Ю. Л., Даниелян М. О., Агеев Ф. Т., Гиляревский С. Р., Беленков Ю. Н., Середенина Е. М. Какие вопросы задаются и на какие вопросы способны ответить исследования по немедикаментозному лечению пациентов с сердечной недостаточностью. Уроки исследования ШАНС. Журнал Сердечная Недостаточность. 2014;15 (6):383–96 [Mareev V. Yu., Begrambekova Yu. L., Danielyan M. O., Ageev F. T., Gilyarevskij S. R., Belenkov Yu. N., Seredenina E. M. Kakie voprosy` zadayutsya i na kakie voprosy` sposobny` otvetit` issledovaniya po nemedikamentoznomu lecheniyu paczientov s serdechnoj nedostatochnost`yu. Uroki issledovaniya ShANS. Zhurnal Serdechnaya Nedostatochnost`. 2014;15 (6):383–96].
  17. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению хронической сердечной недостаточности (четвертый пересмотр). Журнал Сердечная Недостаточность. 2013;14 (7):379–472 [Mareev V. Yu., Ageev F. T., Arutyunov G. P., Koroteev A. V., Mareev Yu. V., Ovchinnikov A. G. i dr. Naczional`ny`e rekomenda­czii OSSN, RKO i RNMOT po diagnostike i lecheniyu xronicheskoj serdechnoj nedostatochnosti (chetvyorty`j peresmotr). Zhurnal Serdechnaya Nedostatochnost`. 2013;14 (7):379–472].
  18. Беграмбекова Ю. Л., Дробижев М. Ю., Мареев В. Ю., Кикта С. В. Можно ли сказать что‑то новое о депрессиях у больных хронической сердечной недостаточностью? Журнал Сердечная Недостаточность. 2015;16 (6):360–7 [Begrambekova Yu. L., Drobizhev M. Yu., Mareev V. Yu., Kikta S. V. Mozhno li skazat` chto-to novoe o depressiyax u bol`ny`x xronicheskoj serdechnoj nedostatochnost`yu? Zhurnal Serdechnaya Nedostatochnost`. 2015;16 (6):360–7].
Drobizhev M. Yu., Begrambekova Yu. L., Mareev V. Yu., Kikta S. V. Effects of depression and anxiety on clinical outcomes in patients with CHF. Russian Heart Failure Journal. 2016;17 (2):91–98

To access this material please log in or register

Register Authorize
Ru En